India, Oct. 27 -- Indian shares were moving lower in early trade on Tuesday as investors awaited earnings from major U.S. technology companies and the Federal Reserve's interest-rate decision for dire... Read More
India, Oct. 27 -- On Tuesday, Apple (AAPL) announced a new iMac powered by the M6 chip, offering faster performance and enhanced AI capabilities in its slim all-in-one design. The new iMac is designed... Read More
India, Oct. 27 -- Nautilus Biotechnology, Inc. (NAUT) reported third quarter 2026 financial results and announced progress in its proteomics platform development, including participation in a four-yea... Read More
India, Oct. 27 -- Apple Original Films will premiere Fleetwood Mac: The Chain, the first fully authorized documentary about the legendary rock band, on Apple TV on January 29, 2027. Directed by Frank... Read More
India, Oct. 27 -- NEXGEL, Inc. (NXGL) announced that it has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2), allowing its common stock to continue trading... Read More
India, Oct. 26 -- Xencor, Inc. (XNCR) is up 23.87 percent, gaining $6.01 to $31.19 on Monday. The surge appears to follow positive clinical data announced Sunday for XmAb819, the company's investigati... Read More
India, Oct. 26 -- On Monday, Scienjoy Holding Corporation (SJ) reported higher income in the first half of 2026, compared to the same half last year. Net income attributable to the shareholders rose ... Read More
India, Oct. 26 -- TransCode Therapeutics, Inc. (RNAZ) presented Phase 1a clinical data for TTX-MC138, an investigational RNA-based therapy targeting metastatic cancers, at the European Society for Med... Read More
India, Oct. 26 -- Oruka Therapeutics, Inc. (ORKA) is up 11.69 percent, gaining $9.37 to $89.52 on Monday. The rise follows positive Week 16 results from the company's EVERLAST-B Phase 2b trial evaluat... Read More
India, Oct. 26 -- Can-Fite BioPharma Ltd. (CANF), a clinical-stage biotechnology company developing small molecule therapeutics, announced the final data from its Phase 2a clinical study of namodenoso... Read More